U.S. market Closed. Opens in 19 minutes

ONVO | Organovo Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.3200 - 0.3876
52 Week Range 0.3200 - 1.7400
Beta 0.45
Implied Volatility 596.79%
IV Rank 100.00%
Day's Volume 581,222
Average Volume 76,131
Shares Outstanding 15,365,800
Market Cap 5,378,030
Sector Healthcare
Industry Biotechnology
IPO Date 2012-02-14
Valuation
Profitability
Growth
Health
P/E Ratio -0.34
Forward P/E Ratio N/A
EPS -1.04
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 20
Country USA
Website ONVO
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.
ONVO's peers: SSYS, VJET, DDD, PRLB, MTLS
*Chart delayed
Analyzing fundamentals for ONVO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is good and Health is very weak. For more detailed analysis please see ONVO Fundamentals page.

Watching at ONVO technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ONVO Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙